0001894897-21-000001.txt : 20211122 0001894897-21-000001.hdr.sgml : 20211122 20211122153921 ACCESSION NUMBER: 0001894897-21-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20211122 DATE AS OF CHANGE: 20211122 EFFECTIVENESS DATE: 20211122 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Nexosome Oncology Holdings, Inc. CENTRAL INDEX KEY: 0001894897 IRS NUMBER: 873247597 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-422096 FILM NUMBER: 211432301 BUSINESS ADDRESS: STREET 1: 8700 CORPORATE DRIVE STREET 2: SUITE 403 CITY: LEXINGTON STATE: KY ZIP: 40503 BUSINESS PHONE: (301) 502-3655 MAIL ADDRESS: STREET 1: 8700 CORPORATE DRIVE STREET 2: SUITE 403 CITY: LEXINGTON STATE: KY ZIP: 40503 D 1 primary_doc.xml X0708 D LIVE 0001894897 Nexosome Oncology Holdings, Inc. 8700 CORPORATE DRIVE SUITE 403 LEXINGTON KY KENTUCKY 40503 (301) 502-3655 DELAWARE None None Corporation true 2021 Todd Hembrough 8700 Corporate Drive Suite 403 Lexington KY KENTUCKY 40503 Executive Officer Director Brian Brohman 8700 Corporate Drive Suite 403 Lexington KY KENTUCKY 40503 Director Alan Ezrin 8700 Corporate Drive Suite 403 Lexington KY KENTUCKY 40503 Director Robert Saunders 8700 Corporate Drive Suite 403 Lexington KY KENTUCKY 40503 Director Matthew Dicken 8700 Corporate Drive Suite 403 Lexington KY KENTUCKY 40503 Director Other Health Care Decline to Disclose 06b false 2021-11-05 false true false 0 4000000 3652126 347874 Total amount sold includes conversion of equity participation agreements. false 48 0 0 0 false Nexosome Oncology Holdings, Inc. /s/ Todd Hembrough Todd Hembrough Chief Executive Officer 2021-11-22